Centre Hospitalier Regional De La Citadelle — Clinical Trial Site

128 Registered trials

64 Currently recruiting

Organisation

Centre Hospitalier Regional De La Citadelle

Location

Liege, Belgium

Identifier

ORG-100028257

Address

Boulevard Quatorzieme-De-Ligne 1, 4000, Belgium

Departments

-
102:Neurologie
1113: Oncology
354844, Centre de Référence des Maladies Neuromusculaires
446: Laboratoire
Anesthesiology
Cardiologie pédiatrique
Cardiology
Cardiovascular Department
Center for Reproductive Medicine
Centre de Réference des Maladies Neuromusculaires (CRMN)
Department Hématologie et oncologie pédiatrique
Department of Pediatric Hemato-Oncology
Department of Pediatric Nephrology
Gastro Enterology
gastro-entérologie, hépatologie et nutrition pédiatrique
Gastroenterology (Pediatric)
Gynécologie - Obstétrique
Haematology
Haematology Department
Hémato - oncologie pédiatrique
Hémato-Oncologie
Hématologie
Hematology
Hémotologie et oncologie pédiatrique
Intensive Care
Intensive Care Unit
Medial Oncology
Medical Oncology Department
N/A
Neonatology
Nephrology
Neuro paediatry
Neuro pediatry
Neurology
Oncology
Paediatric haemato oncology
Paediatric haemato-oncology
Paediatric Haematology and oncology
Paediatric neurology
Paediatrics
Pediatric gastroenterology
Pediatric hemato-oncology
Pediatric hemato-oncology department
Pediatric hematology and oncology
Pediatric neurology
Pediatric Rheumatology
Pediatrics
Physician
Pneumolgy
Pneumologie
Pneumologie - Allergologie
Pneumologie-Allergologie
Pneumology
Pneumology Department
Pulmonology
Reference Center for Neuromuscular Diseases (CRMN)
Rheumatology
Sleep Department
University Department of Neuropediatrics

Clinical trials at this site (128)

Search interface

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Dose Comparison and Exploratory Efficacy Study of Orally Administered SAT-3247 in A… Recruiting

2025-522522-13-01 Duchenne muscular dystrophy 4 2026-04-08
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy Recruiting

2024-520130-29-00 Spinal Muscular Atrophy 4 2025-12-17
A phase 3b study of depemokimab on airway structure and function in patients with type 2 asthma utilizing quantitative high-resolution CT an… Recruiting

2024-519976-19-00 Asthma with type 2 inflammation characterized by an eos 5 2025-11-26
TRITON-CM: A Study to Evaluate Nucresiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Recruiting

2024-519917-72-00 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amy 5 2025-10-29
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-to-Severe Asthma Recruiting

2024-517866-40-00 Moderate-to-severe Asthma 4 2025-09-29
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-line Treatment of PD-L1-high Metastatic Non-small Cell Lung… Recruiting

2024-517780-24-00 Lung Cancer 5 2025-09-18
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure and a weak pumping functio… Recruiting

2024-519525-38-00 Heart failure 5 2025-08-22
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) Recruiting

2024-517529-26-00 Chronic Inflammatory Demyelinating Polyneuropathy 5 2025-08-04
A study on the immune response and safety of an investigational chickenpox vaccine when given to healthy children 12 to 15 months of age. Recruiting

2024-515869-33-00 Varicella 5 2025-07-08
A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping t… Recruiting

2024-517584-23-00 Duchenne Muscular Dystrophy 9 2025-05-16
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting

2023-506460-14-00 Chronic kidney disease (CKD) and hypertension. 5 2025-05-07
PRESERVE-003: ONC-392 (Study Drug) Versus Docetaxel (Standard of Care) in Metastatic Non-small Cell Lung Cancer That Progressed on PD-1/PD-L… Recruiting

2023-505311-20-01 Metastatic Non-Small Cell Lung Cancer 5 2025-03-21
An Ophthalmic Safety Study of New Investigational Drug in Breast Cancer Patients Recruiting

2024-512161-14-00 Breast Cancer 3 2025-01-14
ZELA trial: Phase 2b/3 Multicenter Study to Evaluate the Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developi… Recruiting

2024-513420-41-00 prematurity in neonates 10 2025-01-09
A WORLD-WIDE CLINICAL STUDY TO FIND OUT IF INTRAVENOUS RECOMBINANT HUMAN PLASMA GELSOLIN IS SAFE AND IS BENEFICIAL FOR TREATING ACUTE RESPIR… Recruiting

2023-510109-16-00 Acute Respiratory Distress Syndrome (ARDS) Due to Pneum 4 2025-01-06
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma Recruiting

2024-512113-41-00 Severe Asthma 5 2024-11-20
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis Recruiting

2023-508817-18-00 Perennial Allergic Rhinitis (PAR) 5 2024-10-08
FREE-study Recruiting

2024-516277-68-00 Crohn's disease Ulcerative colitis 6 2024-09-19
A Study to Investigate the Pharmacokinetics (PK) and Safety of Risdiplam in Infants with Spinal Muscular Atrophy Recruiting

2023-505602-42-00 Spinal Muscular Atrophy (SMA) 4 2024-04-30
COLchicine in BElgium in patients with coronary artery disease after Percutaneous Coronary Intervention Recruiting

2023-505028-74-00 Coronary artery disease 5 2024-01-29
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for SC use) versus plac… Recruiting

2022-502046-28-00 HER2-Positive, PIK3CA Mutated, Locally Advanced or Meta 5 2023-12-22